Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...
In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...